Physician profile
Samuel Jonathan Hess
NPI 1467434118
$2,238.90
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2022: $16.54 · 2023: $614 · 2024: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $450 · Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $450.00 |
| Food and Beverage | $272.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Henry Schein, INC. | $1,500.00 | 2019 | |
| Choice Spine, LLC | $450.00 | 2023 | Triton |
| Royal Biologics, INC. | $153.97 | 2023-2024 | |
| Integrity Implants INC. Dba Accelus | $58.16 | 2023 | |
| Southern Edge Orthopaedics, INC. | $36.56 | 2024 | |
| Djo, LLC | $23.67 | 2024 | Cmf |
| Bioventus LLC | $16.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.